Episode 6: Tomas Philipson – Free Riders and Price Controls: The Global Economics of Drug Innovation
In this episode, Tomas Philipson, a professor at the University of Chicago and former acting chair of the Council of Economic Advisors, alongside financial analyst Thom Gunderson and pharmaceutical expert Briana Mayer, discusses drug innovation, pricing policies, and the role of the FDA in the drug…
What Does Socialism Mean to You?
On this episode of The Middle, we're asking what socialism means to you. The United States just overthrew Venezuela's socialist President Nicholas Maduro and now, the Mayor of America’s biggest city is a democratic socialist. Just the word “socialism” can have different meanings depending on who yo…
DC EKG: Economist Tomas Philipson, Part III
Part III of Joe and Eric’s talk with economist Tomas Philipson focuses on his role as acting head of the Council of Economic Advisers from the start of the Covid crisis. What it was like to watch the “blue collar boom” and 3%+ GDP growth get undone by the pandemic, and how public health attitudes …
DC EKG: Economist Tomas Philipson, Part II
In the second part of a three-part interview, hosts Joe Grogan and Eric Ueland glean more gems from University of Chicago economist, Tom Philipson. Discussed are the damaging results of the two-year decline in US real wages, market volatility caused by government largesse, and the asymmetrical focu…
DC EKG: Talks w/ Economist Tomas Philipson, Part I
From the public announcements of discontinued research, the fuzzy CBO math that is under-counting the reductions in cures, to the bloated use of taxpayer dollars to implement price control. Its a data rich discussion that's sure to send shivers down the spines of policymakers, practitioners , and p…
Can Clinical Trial Failure Be Insured? A Conversation with Tomas Philipson
Dr. Tomas Philipson, former Acting Chairman of the White House Council of Economic Advisers and Professor Emeritus at the University of Chicago, joins Perspectives by the Leerink Center for Pharmacoeconomics to discuss a new insurance model he developed that insures biotech investments against clin…
Can Clinical Trial Failure Be Insured? A Conversation with Tomas Philipson
Dr. Tomas Philipson, former Acting Chairman of the White House Council of Economic Advisers and Professor Emeritus at the University of Chicago, joins Perspectives by the Leerink Center for Pharmacoeconomics to discuss a new insurance model he developed that insures biotech investments against clin…
Right Diagnosis, Wrong Cure: Examining the True Cost of Drug Price Controls
In this episode, Mercatus Research Fellow Satya Marar speaks with Tomas Philipson, former Acting Chair of the Council of Economic Advisers and Professor at the University of Chicago, about the evidence behind drug price controls and their effects on healthcare affordability, pharmaceutical innovati…
PODCAST SEARCH ENGINE
You can use our website to search 3,821,620 podcasts and 195,400,438 episodes by people, places, or topics.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
EDIT
Thank you for helping to keep the podcast database up to date.
